5
Artillegence Bio-Innovations Ltd
512642 BSE
Artillegence Bio-Innovations Ltd
Financial Services BSE: 512642 Finance
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Artillegence Bio-Innovations Ltd insights
29 extracted metrics + investor summaries across FY06–FY12.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.10 times its book value
Weaknesses
4- The company has delivered a poor sales growth of -27.2% over past five years.
- Company has a low return on equity of -0.35% over last 3 years.
- Company has high debtors of 260 days.
- Working capital days have increased from 1,486 days to 3,178 days
Growth Rate
Revenue Growth
-93.00% →
Net Income Growth
-100.00% →
Cash Flow Change
-
ROE
0.00% ↗
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.28 | 0.21 | 0.03 | 0.03 | 0.02 | 0 | 0.02 | 0.7 | 0 | 0 | 0.01 | 0.04 | 0 |
| Expenses | 0.28 | 0.22 | 0.01 | 0.03 | 0.02 | 0 | 0.01 | 0.7 | 0 | 0 | 0 | 0.04 | 0.01 |
| Operating Profit | 0 | -0.01 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | -0.01 |
| OPM % | 0% | -4.76% | 66.67% | 0% | 0% | — | 50% | 0% | — | — | 100% | 0% | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | -0.01 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | -0.01 |
| Tax % | — | 0% | 0% | — | — | — | 0% | — | — | — | 0% | — | 0% |
| Net Profit | 0 | -0.01 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | -0.01 |
| EPS in Rs | 0 | -0.01 | 0.03 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | -0.01 |
Profit & Loss
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 8.42 | 11.55 | 4.44 | 9.9 | 11.8 | 9.57 | 2.36 | 0.05 |
| Expenses | 8.43 | 11.55 | 4.45 | 9.91 | 11.8 | 9.91 | 2.37 | 0.05 |
| Operating Profit | -0.01 | 0 | -0.01 | -0.01 | 0 | -0.34 | -0.01 | 0 |
| OPM % | -0.12% | 0% | -0.23% | -0.1% | 0% | -3.55% | -0.42% | — |
| Other Income | 0.01 | 0 | 0.01 | 0.02 | 0 | 0.06 | 0.01 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 0 | 0 | 0.01 | 0 | -0.28 | 0 | 0 |
| Tax % | — | — | — | 0% | — | 0% | — | — |
| Net Profit | 0 | 0 | 0 | 0.01 | 0 | -0.28 | 0 | 0 |
| EPS in Rs | 0 | 0 | 0 | 0.01 | 0 | -0.38 | 0 | 0 |
| Div. Payout % | — | — | — | 0% | — | 0% | — | — |
Balance Sheet
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 |
| Reserves | 19.29 | 19.29 | 19.29 | 19.3 | 19.31 | 19.03 | 19.03 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.05 | 0.03 | 4.7 | 12.56 | 8.83 | 0.69 | 0 |
| Total Liabilities | 26.66 | 26.64 | 31.31 | 39.18 | 35.46 | 27.04 | 26.35 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.58 | 0.9 | 1.15 | 17.59 | 6.64 | 8.37 | 5.76 |
| Other Assets | 25.08 | 25.74 | 30.16 | 21.59 | 28.82 | 18.67 | 20.59 |
| Total Assets | 26.66 | 26.64 | 31.31 | 39.18 | 35.46 | 27.04 | 26.35 |
Cash Flow
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Operating | -0.02 | -0.07 | -0.43 | 16.63 | -10.56 | — | — |
| Investing | 0 | 0.68 | -0.26 | -16.44 | 10.95 | — | — |
| Financing | 0 | 0 | 0 | 0 | 0 | — | — |
| Net Cash Flow | -0.02 | 0.61 | -0.69 | 0.19 | 0.39 | — | — |
| Free Cash Flow | -0.02 | -0.07 | -0.43 | 16.63 | -10.56 | — | — |
| CFO/OP | 200 | — | 4,300 | -1,66,300 | — | — | — |
Ratios
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 322 | 144 | 228 | 41.29 | 22.27 | 64.08 | 260 |
| Inventory Days | 130 | 159 | 773 | 63.85 | 293 | 162 | 1,285 |
| Days Payable | 0.87 | 0 | 0 | 192 | 49.35 | 26.29 | 0 |
| Cash Conversion Cycle | 451 | 303 | 1,001 | -87.14 | 266 | 200 | 1,544 |
| Working Capital Days | 1,078 | 788 | 2,086 | 323 | 598 | 683 | 3,178 |
| ROCE % | — | 0% | 0% | 0.04% | 0% | -1.06% | 0% |
Documents
4
Updates
21 February 2026 - Applied (10 Feb 2026) to reclassify promoters: Jyoti Kuthari 14,58,567 (0.94%); R. Suchanti 20,000 (0.01%); V. K. Jain 2,000 (0.01%). 21 February 2026 - Applied (10 Feb 2026) to reclassify promoters: Jyoti Kuthari 14,58,567 (0.94%); R. Suchanti 20,000 (0.01%); V. K. Jain 2,000 (0.01%).
5
Copy of Newspaper Publication
19 February 2026 - Unaudited financial results for quarter/nine months ended 31 Dec 2025 published 17 Feb 2026. 19 February 2026 - Unaudited financial results for quarter/nine months ended 31 Dec 2025 published 17 Feb 2026.
Frequently Asked Questions about Artillegence Bio-Innovations Ltd
What does Artillegence Bio-Innovations Ltd do?
Artillegence Bio-Innovations Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in finance and investment businesses.
Where is Artillegence Bio-Innovations Ltd (512642) listed?
Artillegence Bio-Innovations Ltd is listed on the Indian stock exchanges. It is listed on BSE: 512642. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Artillegence Bio-Innovations Ltd belong to?
Artillegence Bio-Innovations Ltd operates in the Financial Services sector within the Finance industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Artillegence Bio-Innovations Ltd on Tapetide?
On Tapetide, you can view Artillegence Bio-Innovations Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Artillegence Bio-Innovations Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in finance and investment businesses.
Website artillegencebio.com
Face Value ₹ 10